Medicare AdvantageCoverageMedium impact
MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross·Podiatry, Dermatology, Family Medicine +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.014h regarding debridement of mycotic and symptomatic non-mycotic hypertrophic toe nails has been reissued with an effective date of April 1, 2026. This is a policy update that affects coverage and billing for toe nail debridement procedures under Medicare Advantage plans.
Action Required
Before April 1, 2026: Billing team should review the full policy details at the source URL to understand specific coverage changes for toe nail debridement procedures. Update billing guidelines and ensure providers are aware of any new requirements for mycotic and non-mycotic hypertrophic toe nail debridement under Medicare Advantage plans.